Galapagos | Netto Inntekt



Net Income Endring Dato
argenx SE USD 774.16M 682.75M 2024-12
AstraZeneca USD 2.92B 1.42B 2025-03
Biogen USD 266.7M 121.8M 2024-12
Genmab DKK 3.84B 2.58B 2024-12
Gilead Sciences USD 1.78B 529M 2024-12
GlaxoSmithKline GBP 1.62B 1.21B 2025-03
GRIFOLS EUR 68.97M 17.28M 2024-12
Hikma Pharmaceutical USD 226M 167M 2024-06
Incyte USD 158.2M 43.01M 2025-03
Merck EUR 667M 142M 2024-12
Neurocrine Biosciences USD 103.1M 26.7M 2024-12
Novartis USD 2.82B 371M 2024-12
Roche Holding CHF 1.01B 2.12B 2024-12
Sanofi EUR 1.87B 1.37B 2025-03
UCB EUR 104M 72M 2024-06
Vertex Pharmaceuticals USD 913M 132.4M 2024-12



Galapagos Netto Inntekt - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2025.